US$ 23.58
parkinson glutathione oxidative ipsc crispr CRISPR-Cas9: “New CRISPY Parkinson's research” – The Science of Parkinson's CRISPR-Cas9-Based Technology and Its Relevance
Description
However, despite the evident anti-cancer potential of inhibitors targeting this axis (Kahn, 2014), their translation from research labs to clinical application has encountered numerous obstacles

Adachi S, Miura S, Shiga Y, Arimura T, Kuwano T, Kitajima K, et al

1014 mm: Moderate activity

Metabolism of the food-associated carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine by human intestinal microbiota
